A Study to Compare Two Paracetamol Formulations.

GlaxoSmithKline (GSK)

Status and phase: Completed; Phase 1

Conditions: Pain

Treatments: Drug: Experimental paracetamol formulation; Drug: Marketed paracetamol

Study type: Interventional

Funder types: Industry

Identifiers

NCT01592227

A6480791

Details and patient eligibility

About

A pharmacokinetic study investigating the rate and extent of absorption of paracetamol and an adjuvant from two different paracetamol formulations.

Enrollment: 30 patients

Sex: All

Ages: 18 to 55 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Healthy male or female volunteers aged 18-55 years with a body mass index ranging from 19-28 kilograms per square meter who have given informed consent

Trial design

30 participants in 2 patient groups

Marketed paracetamol

Active Comparator group

Description:

Marketed paracetamol

Treatment:

Drug: Marketed paracetamol

Experimental paracetamol formulation

Experimental group

Description:

Experimental formulations

Treatment:

Drug: Experimental paracetamol formulation